Figure 2From: Efficacy of plasma vascular endothelial growth factor in monitoring first-line chemotherapy in patients with advanced non-small cell lung cancer Distribution of plasma VEGF levels in various response groups. Median and interquartile range along with minimum and maximum values and outliers of the baseline values of the VEGF before start of therapy cycle 1 (pre-treatment; BV1), cycle 2 (BV2), and cycle 3 (BV3) are given.Back to article page